Managing sleep disturbance during the menopause transition

Baker FC Zambotti M Colrain IM , et al. Sleep problems during the menopausal transition: prevalence, impact, and management challenges. Nat Sci Sleep 2018; 10: 73–95.

Kalmbach DA Kingsberg SA Roth T , et al. Sexual function and distress in postmenopausal women with chronic insomnia: exploring the role of stress dysregulation. Nat Sci Sleep 2019; 11: 141–153.

MacGregor EA . Migraine, menopause and hormone replacement therapy. Post Reprod Health 2018; 24: 11–18.

Caruso D Masci I Cipollone G , et al. Insomnia and depressive symptoms during the menopausal transition: theoretical and therapeutic implications of a self-reinforcing feedback loop. Maturitas 2019; 123: 78–81.

Hogervorst E Craig J O’Donnell E . Cognition and mental health in menopause: a review. Best Pract Res Clin Obstet Gynaecol 2022; 81: 69–84.

Thurston RC Chang Y Kline CE , et al. Trajectories of sleep over midlife and incident cardiovascular disease events in the study of women’s health across the nation. Circulation 2024; 149: 545–555.

Zhou Y Yang R Li C , et al. Sleep disorder, an independent risk associated with arterial stiffness in menopause. Sci Rep 2017; 7: 1904.

Hirshkowitz M Whiton K Albert SM , et al. National sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health 2015; 1: 40–43.

Consensus Conference Panel . Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep 2015; 38: 843–844.

Hirshkowitz M Whiton K Albert SM , et al. National sleep Foundation’s updated sleep duration recommendations: final report. Sleep Health 2015; 1: 233–243.

Baker FC Willoughby AR Sassoon SA , et al. Insomnia in women approaching menopause: beyond perception. Psychoneuroendocrinology 2015; 60: 96–104.

Proserpio P Marra S Campana C , et al. Insomnia and menopause: a narrative review on mechanisms and treatments. Climacteric 2020; 23: 539–549.

Ciano C King TS Wright RR , et al. Longitudinal study of insomnia symptoms among women during perimenopause. J Obstet Gynecol Neonatal Nurs 2017; 46: 804–813.

Riemann D Espie CA Altena E , et al. The European insomnia guideline: an update on the diagnosis and treatment of insomnia 2023. J Sleep Res 2023; 32: e14035.

Silva AAd Lima LdPPT Maldonado CF , et al. The impact of postmenopause on sleep and sleep disorders: the current state of the art. Res Soc Dev 2023; 12: e76121343961.

Freedman RR Roehrs TA . Sleep disturbance in menopause. Menopause 2007; 14: 826–829.

Baker FC . It’s not just about the hot flashes: Menopausal hormone changes and disrupted sleep. J Clin Endocrinol Metab 2023; 108: e25–e26.

Kalmbach DA Cheng P Arnedt JT , et al. Treating insomnia improves depression, maladaptive thinking, and hyperarousal in postmenopausal women: comparing cognitive-behavioral therapy for insomnia (CBTI), sleep restriction therapy, and sleep hygiene education. Sleep Med 2019; 55: 124–134.

Takacs P Majoros A Larson K . Nocturia and hormone therapy: impact on sleep? Menopause 2021; 28: 482–483.

Frange C Hachul H Hirotsu C , et al. Insomnia with musculoskeletal pain in postmenopause: associations with symptoms, mood, and quality of life. J Menopausal Med 2018; 24: 17–28.

National Institute for Health and Care Excellence. Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s . NICE guideline NG202. London : NICE ; 2021 . Available from: https://www.nice.org.uk/guidance/ng202

Luca G Haba Rubio J Andries D , et al. Age and gender variations of sleep in subjects without sleep disorders. Ann Med 2015; 47: 482–491.

National Institute for Health and CareScenario Excellence. : Management | Restless legs syndrome: management. CKS topic. London: NICE. Available from: https://cks.nice.org.uk/topics/restless-legs-syndrome/management/management/

National Institute for Health and Care Excellence. Insomnia. CKS topic. London: NICE. Available from: https://cks.nice.org.uk/topics/insomnia/

Schutte -Rodin S Broch L Buysse D , et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008; 04: 487–504.

NHS. Fall asleep faster and sleep better – Every Mind Matters. London: NHS; 2021. Available from: https://www.nhs.uk/every-mind-matters/mental-wellbeing-tips/how-to-fall-asleep-faster-and-sleep-better/

Chow CM . Sleep hygiene practices: where to now? Hygie 2022; 2: 146–151.

Department for Transport . Assessing fitness to drive: a guide for medical professionals . GOV.UK ; 2024 . Available from: https://www.gov.uk/government/publications/assessing-fitness-to-drive-a-guide-for-medical-professionals

Cintron D Lahr BD Bailey KR , et al. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Menopause N Y N 2018; 25: 145–153.

Geiger PJ Eisenlohr-Moul T Gordon JL , et al. Effects of perimenopausal transdermal estradiol on self-reported sleep, independent of its effect on vasomotor symptom bother and depressive symptoms. Menopause 2019; 26: 1318–1323.

Pan Z Wen S Qiao X , et al. Different regimens of menopausal hormone therapy for improving sleep quality: a systematic review and meta-analysis. Menopause N Y N 2022; 29: 627–635.

Nolan BJ Liang B Cheung AS . Efficacy of micronized progesterone for sleep: a systematic review and meta-analysis of randomized controlled trial data. J Clin Endocrinol Metab 2021; 106: 942–951.

Lancel M Faulhaber J Holsboer F , et al. Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. Am J Physiol 1996; 271: E763–772.

Montplaisir J Lorrain J Denesle R , et al. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause 2001; 8: 10–16.

Andréen L Sundström-Poromaa I Bixo M , et al. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 2005; 30: 212–224.

Djapardy V Panay N . Alternative and non-hormonal treatments to symptoms of menopause. Best Pract Amp Res Clin Obstet Amp Gynaecol 2022; 81: 45–60.

Maki PM Panay N Simon JA . Sleep disturbance associated with the menopause. Menopause 2024; 31: 724–733.

Shapiro CM Cano A Nappi RE Santoro N English ML Mancuso S et al. Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause . Maturitas. 2024; 175: 1–9.

Simon J Anderson RA Ballantyne E , et al. OR11-03 NT-814, a non-hormonal dual neurokinin 1, 3 receptor antagonist markedly improves vasomotor symptoms in post-menopausal women; results of a randomised, double-blind, placebo-controlled, dose-finding study (SWITCH-1). J Endocr Soc 2020; 4: OR11.

National Institute for Health and Care Excellence. Menopause: identification and management. NICE guideline NG23. London: NICE; 2015. Available from: https://www.nice.org.uk/guidance/ng23

Carmona NE Starick E Millett GE , et al. Sleep effects of psychological therapies for menopausal symptoms in women with hot flashes and night sweats: a systematic review. Post Reprod Health 2024; 30: 166–181.

Kalmbach DA Cheng P Arnedt JT , et al. Improving daytime functioning, work performance, and quality of life in postmenopausal women with insomnia: comparing cognitive behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education. J Clin Sleep Med 2019; 15: 999–1010.

National Institute for Health and Care Excellence. Insomnia. CKS topic. London: NICE. Available from: https://cks.nice.org.uk/topics/insomnia/#!scenarioRecommendation

Sateia MJ . International classification of sleep disorders-third edition. Chest 2014; 146: 1387–1394.

American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.

Gursoy AY Kiseli M Caglar GS . Melatonin in aging women. Climacteric 2015; 18: 790–796.

Wilson S Anderson K Baldwin D , et al. British association for psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. J Psychopharmacol 2019; 33: 923–947.

National Institute for Health and Care Excellence. Daridorexant for treating long-term insomnia. NICE technology appraisal guidance TA922. London: NICE; 2023. Available from: https://www.nice.org.uk/guidance/ta922

Dauvilliers Y Zammit G Fietze I Mayleben D Seboek Kinter D Pain S et al. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials . Lancet Neurol. 2022; 21(2): 125–39.

Watson NF Benca RM Krystal AD , et al. Alliance for sleep clinical practice guideline on switching or deprescribing hypnotic medications for insomnia. J Clin Med 2023; 12: 2493.

Bonsignore MR Saaresranta T Riha RL . Sex differences in obstructive sleep apnoea. Eur Respir Rev; 28: 190030. Epub ahead of print 31 December 2019.

Lindberg E Bonsignore MR Polo-Kantola P . Role of menopause and hormone replacement therapy in sleep-disordered breathing. Sleep Med Rev 2020; 49: 101225.

Orbea CAP Lloyd RM Faubion SS , et al. Predictive ability and reliability of the STOP-BANG questionnaire in screening for obstructive sleep apnea in midlife women. Maturitas 2020; 135(1–5): 1–5.